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Reaction of 3H-quinazoline-4-thione (1) with two mole equivalents of an 
alkyllithium (t-BuLi, n-BuLi or MeLi) at -78 C in dry THF gave the 
corresponding 2-alkyl-1,2-dihydro-3H-quinazoline-4-thione (4, 5 or 6) in 
high yield. Similarly, reactions of 4-(methylthio)quinazoline (7), 
4-(ethylthio)quinazoline (8) and 4-methoxyquinazoline (9) with 
alkyllithiums (one mole equivalent) gave the corresponding 4-substitued 
2-alkyl-1,2-dihydroquinazolines 11-18. On the other hand, blocking 
position 2 with a phenyl group in 4-(methylthio)-2-phenylquinazoline (20) 
and 4-methoxy-2-phenylquinazoline (21) resulted in reaction with two 
mole equivalents of alkyllithiums to give 4,4-dialkyl-2-phenyl-3,4-
dihydroquinazolines 22-24. 
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1. Introduction 
Quinazoline derivatives exhibit a wide variety of pharmacological activities [1-8]. 
Therefore methods for the synthesis and/or modification of this ring system are 
always of interest. Reactions of organic compounds with organolithium reagents offer 
useful opportunities for the production of modified derivatives [9-13]. However, the 
literature reveals that there are only a few reports of syntheses of substituted 
quinazoline derivatives via such reactions [14-22]. As part of our interest in the use of 
organolithium reagents in organic synthesis [23-28], we have investigated the ring and 
side-chain lithiation of various 3H-quinazolin-4-ones for the production of derivatives 
substituted and/or modified at the 2-position, which might be difficult to prepare by 
other means [29-36]. However, while many of these reactions were successful, 
2,3-unsubstituted 3H-quinazolin-4-one was recovered unchanged after treatment with 
either an alkyllithium or lithium diisopropylamide (LDA) followed by treatment with 
an electrophile. It was of interest to carry out analogous reactions with 
3H-quinazoline-4-thione and its derivatives in order to investigate whether the 
presence of sulfur instead of oxygen would have any significant influence. 
In the present work we report the reaction of alkyllithiums with 
3H-quinazoline-4-thione, resulting in addition at the 2-position. We also report 
reactions of alkyllithiums with 4-alkylthio- and 4-methyoxyquinazolines, which also 
result in addition to the 2-position. By contrast, we report that 4-(methylthio)-
2-phenyl- and 4-methoxy-2-phenyl-quinazolines undergo addition and substitution at 
the 4-position to give 4,4-dialkyl-2-phenyl-3,4-dihydroquinazolines. 
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2. Results and discussion 
3H-Quinazoline-4-thione (1) was prepared from 3H-quinazolin-4-one (2) according to 
the literature procedure [37]. It was found that reaction of 1 with two mole equivalents 
of an alkyllithium (tert-butyllithium, n-butyllithium or methyllithium) occurred 
smoothly at -78 C in dry THF, and resulted in the production of the corresponding 
2-alkyl-1,2-dihydro-3H-quinazoline-4-thione 4, 5 or 6 in high yield (Scheme 1). This 
contrasts sharply with the situation for 3H-quinazolin-4-one (2), which resulted in 
recovery of unchanged 2 under such conditions, and indicates the important role 
played by sulfur in this reaction. Although we have not yet investigated the reasons 
for this difference, it is possible that the thiolate anion in 3 is less effective at donating 
negative charge to the ring than its oxygen counterpart. The acquisition of negative 
charge by the ring would be expected to deactivate the ring towards nucleophilic 
attack by organolithium reagents. 
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The structures of compounds 4-6 were confirmed by 
1
H NMR, 
13
C NMR, and 
both low and high resolution mass spectral data (see experimental section for details). 
The 
1
H NMR spectra showed a characteristics H2 signal in the  4.75-4.32 ppm range 
while the 
13
C NMR spectra showed that C2 appeared as a doublet in the  72-61 ppm 
region. 
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Although it was interesting to note that compound 1 was far more reactive 
towards organlithium reagents than was compound 2, the nature of the products of the 
reaction (i.e. addition products) was not very useful. Therefore, an attempt was made 
to bring about lithiation with a less nucleophilic base, LDA. In order to determine 
whether lithiation had occurred, benzophenone was added as electrophile prior to 
work up. Unfortunately only starting material was recovered, indicating that no 
lithiation took place at position 2 under the conditions tried. 
Our attention was therefore turned next to the reactions of alkyllithiums with 
compounds having alkylthio or alkoxy groups at position 4, in order to see what effect 
the sulfur atom would have on the reactivity of such compounds. 
4-(Methylthio)quinazoline (7), 4-(ethylthio)quinazoline (8) and 4-methoxyquinazoline 
(9) were all prepared according to literature procedures [37-40]. It was found that 
reactions of compounds 7-9 with alkyllithiums (t-BuLi, n-BuLi, MeLi) occurred 
smoothly and rapidly at –78 C in dry THF. The lithium reagents 10a-c were 
presumably obtained as intermediates and after quenching with aqueous NH4Cl 
solution gave the corresponding 4-substituted 2-alkyl-1,2-dihydroquinazolines 11-18 
(Scheme 2) in high yields (Table 1). LDA did not react with 7-9 under similar 
conditions. 
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Table 1. Synthesis of 4-substituted 2-alkyl-1,2-dihydroquinazolines 11-18 according 
to Scheme 2. 
 
Product X R' R Yield (%)
a
 
11 S Me n-Bu 90 
12 S Me t-Bu 88 
13 S Me Me 89 
14 S Et n-Bu 91 
15 S Et t-Bu 89 
16 O Me n-Bu 89 
17 O Me t-Bu 89 
18 O Me Me 94 
a
 Yield of isolated, purified product. 
 
As indicated in Table 1, the yields of compounds 11-18 are extremely good in 
all cases. The structures of compounds 11-18 were confirmed by 
1
H NMR, 
13
C NMR, 
and both low and high resolution mass spectral data (see experimental section for 
details). The 
1
H NMR spectra showed a characteristic H2 signal in the  = 4.99-4.37 
ppm range while the 
13
C NMR spectra showed that C2 appears as a doublet in the  = 
79-66 ppm region. 
 The above results showed few major differences between compounds 7 and 9. 
However, the reaction of excess t-BuLi with 4-methoxyquinazoline (9) was different 
than that with 4-(methylthio)quinazoline (7). The reaction of t-BuLi with 9 gave a 
mixture of 2-tert-butyl-4-methoxy-1,2-dihydroquinazoline (17) and 2-tert-butyl-1,2-
dihydro-1H-quinazolin-4-one (19) (Scheme 3), in proportions that depended on the 
amount of t-BuLi used (Table 2). Compound 19 was the very product that might have 
been expected from the reaction of 3H-quinazolin4-one (2) with tert-butylithium, but, 
of course, this direct reaction of 2 with t-BuLi did not occur. 
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Table 2. Yields of 17 and 19 from reaction of 4-methoxyquinazoline (9) with t-BuLi 
according to Scheme 3. 
 
t-BuLi (mole equiv.) Yield (%)
a
 
17 19 
1.2 89  
1.4 76 6 
2.0 66 15 
2.4 50 27 
3.0 37 42 
a
 Yield of isolated, purified product. 
 
The NMR and mass spectra confirmed the structure of compound 19. The 
1
H 
NMR spectrum showed the presence of two exchangeable singlets which resonated at 
 = 7.11 and 5.75 ppm due to two NH protons, while the singlet due to the OMe group 
had disappeared. The 
13
C NMR spectrum showed that C4 appeared as a singlet at  = 
164.9 ppm and also showed all the other appropriate carbon resonances. The CI mass 
spectrum showed an intense pseudo molecular ion peak (MH
+
) at m/z = 205, and there 
was also a molecular ion peak at m/z = 204 in the EI mass spectrum. The accurate 
mass of the pseudo molecular ion confirms the formula as C12H17N2O (MH
+
). 
In all the reactions so far, the only significant process observed was addition 
of organolithium reagent at position 2. In an attempt to divert reaction to other sites, 
attention was next turned to the reactions of alkyllithiums with 4-(methylthio)-
2-phenylquinazoline (20) [39] and 4-methoxy-2-phenylquinazoline (21) [39], in 
which position 2 was blocked with a phenyl group. Interestingly, when a 1:1 molar 
mixture of 20 and an alkyllithium (n-BuLi or MeLi) was allowed to react for one hour 
at -78 C in dry THF (Scheme 4; X = S), 4,4-dialkyl-2-phenyl-3,4-dihydroquinazoline 
(22 or 23) was obtained in moderate yield (Table 3), along with a significant amount 
of the starting material 20, which was recovered unreacted. Use of 2.2 mole 
equivalents of the alkyllithiums gave 22 and 23 in high yields, presumably via initial 
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addition of alkyllithium, then elimination of methanethiolate anion and further 
addition of alkyllithium. Even with this reactant ratio, however, t-BuLi gave only a 
modest yield of product 24 (Table 3) due to the formation of other by-products. 
 
N
N
XMe
N
NH
RR
i,  RLi, THF,  -78 °C
ii, aq. NH4Cl
22-2420 X = S
21 X = O  
SCHEME 4 
 
Table 3. Synthesis of 4,4-dialkyl-2-phenyl-3,4-dihydroquinazolines 22-24 from 20 
according to Scheme 4 (X = S). 
 
Product RLi (mole quiv.) R Yield (%)
a
 
22 1.1 n-Bu 47 
22 2.2 n-Bu 96 
23 1.1 Me 40 
23 2.2 Me 81 
24 2.2 t-Bu 49
b
 
a
 Yield of isolated, purified product. 
b
 TLC indicated the presence of other products which were difficult to separate. 
 
Reaction of 4-methoxy-2-phenylquinazoline (21) with n-BuLi (4 equivalents) 
has been reported previously [19] to give 4,4-dibutyl-2-phenyl-3,4-
dihydroquinazoline 22. We investigated the reactions of 21 with other alkyllithiums 
under conditions similar to those used for compound 20 in order to have a comparison 
between the effect of methylthio and methoxy groups on the reactivity of the 
quinazoline ring system. It was found that compound 21 behaved similarly to 
compound 20 in its reactions with alkyllithiums. Again it was found that reaction of 
21 with n-BuLi (1.1 equivalent) resulted in the production of 4,4-dibutyl-2-phenyl-
3,4-dihydroquinazoline 22, but in modest yield. However, using two equivalents of 
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alkyllithiums gave 22 and 23 (Scheme 4; X = O) in good yields (Table 4). Again the 
yield of 24 was lower due to the formation of other by-products. 
 
Table 4. Synthesis of 4,4-dialkyl-2-phenyl-3,4-dihydroquinazolines 22-24 from 21 
according to Scheme 4 (X = O). 
 
Product RLi (mole quiv.) R Yield (%)
a
 
22 1.1 n-Bu 46 
22 2.2 n-Bu 88 
23 2.2 Me 83 
24 2.2 t-Bu 49
b
 
a
 Yield of isolated, purified product. 
b
 TLC indicated the presence of other products which were difficult to separate. 
 
The NMR and mass spectra confirmed the structures of compounds 22-24 (see 
experimental section for details). The 
1
H NMR spectra showed the presence of an 
exchangeable singlet which resonated at  = 5.60-4.65 ppm due to the NH proton, 
while the 
13
C NMR spectra showed that C4 appeared as a singlet at  = 68-53 ppm 
and also showed all the other appropriate carbon resonances. 
 
3. Conclusions 
We have demonstrated a convenient procedure that allows regiospecific nucleophilic 
addition of alkyllithiums to 3H-quinazoline-4-thione and various quinazoline 
derivatives containing an alkylthio or a methoxy group at position 4 and a hydrogen 
or a phenyl group at position 2. The procedure provides efficient syntheses of 2-alkyl-
1,2-dhiydroquinazolines, via 1,2-addition of alkyllithiums, and 4,4-dialkyl-3,4-
dihydro-2-phenylquinazolines via 3,4-additon followed by displacement of the 
substituent (SMe or OMe) at position 4. This should be beneficial for the synthesis of 
analogues with potentially useful pharmacological properties. 
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4. Experimental 
Melting point determinations were performed by the open capillary method using a 
Gallenkamp melting point apparatus and are reported uncorrected. 
1
H and 
13
C NMR 
spectra were recorded on a Bruker AV400 spectrometer operating at 400 MHz for 
1
H 
and 100 MHz for 
13
C measurements. Chemical shifts are reported relative to TMS. 
Assignments of signals are based on coupling patterns and expected chemical shift 
values and have not been rigorously confirmed. Signals with similar characteristics 
might be interchanged. Low-resolution mass spectra were recorded on a Quattro II 
spectrometer, electron impact (EI) at 70 eV and chemical ionization (CI) at 50 eV by 
the use of NH3 as ionization gas. Accurate mass data were obtained on a MAT900 
instrument. Column chromatography was carried out using Fischer Scientific silica 
60A (35-70 micron). Alkyllithiums were obtained from Aldrich Chemical Company 
and were estimated prior to use by the method of Watson and Eastham [41]. Other 
chemicals were obtained from Aldrich Chemical Company and used without further 
purification. THF was distilled from sodium benzophenone ketyl. Other solvents were 
purified by standard procedures [42,43]. 
 
4.1 2-Alkyl-1,2-dihydro-3H-quinazoline-4-thiones (4-6); general procedure 
A solution of alkyllithium (2.2 mmol) was added to a cold (-78 C), stirred solution of 
3H-quinazoline-4-thione, 1 (0.16 g, 1 mmol), in anhydrous THF (50 mL) under N2. 
The yellow solution obtained was stirred at –78 C for 1 h. The reaction mixture was 
removed from the cooling bath and allowed to warm to r.t., diluted with Et2O (10 mL) 
then quenched with aq. sat. NH4Cl (10 mL). The organic layer was separated, washed 
with H2O (2 x 10 mL), dried (MgSO4), and evaporated under reduced pressure. The 
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solid obtained was treated with Et2O (10 mL), filtered then dried to give the pure 
product 4, 5 or 6. 
 
2-Butyl-1,2-dihydro-3H-quinazoline-4-thione (4) 
Mp: 119-120 C; 1H NMR (DMSO-d6)  (ppm): 10.13 (s, exch., 1H, NH), 8.04 (dd, J 
= 8, 1 Hz, 1H, H5), 7.25 (app. dt, J = 1, 8 Hz, 1H, H7), 6.92 (s, exch., 1H, NH), 6.73 
(br d, J = 8 Hz, 1H, H8), 6.66 (app. dt, J = 1, 8 Hz, 1H, H6), 4.63 (t, J = 6 Hz, 1 H, 
H2), 1.69-1.64 (m, 2H, CH2), 1.42-1.25 (m, 4H, 2CH2), 0.88 (t, J = 7 Hz, 3H, CH3); 
13
C NMR (DMSO-d6)  (ppm): 189.8 (s, C4), 144.7 (s, C8a), 134.1 (d, C7), 131.9 (d, 
C5), 120.0 (s, C4a), 117.5 (d, C6), 115.1 (d, C8), 64.8 (d, C2), 33.8 (t, CH2), 25.8 (t, 
CH2), 22.3 (t, CH2), 14.3 (q, CH3); EI-MS: m/z (%) = 220 (M
+
, 21), 176 (13), 163 
(100), 145 (9), 136 (10), 129 (12), 41 (84); CI-MS: m/z (%) = 221 (MH
+
, 100), 187 
(18), 163 (7); HRMS: m/z calcd for C12H17N2S (MH
+
), 221.1107; found, 221.1105. 
 
2-tert-Butyl-1,2-dihydro-3H-quinazoline-4-thione (5) 
Mp: 166-167 C; 1H NMR (DMSO-d6)  (ppm): 9.97 (br s, exch., 1 H, NH), 8.01 (dd, 
J = 8, 1 Hz, 1H, H5), 7.22 (app. dt, J = 1, 8 Hz, 1H, H7), 7.05 (br s, exch., 1H, NH), 
6.74 (d, J = 8 Hz, 1H, H8), 6.55 (app. t, J = 8 Hz, 1H, H6), 4.32 (app. t, J = 4 Hz, 1H, 
H2), 0.88 [s, 9 H, C(CH3)3]; 
13
C NMR (DMSO-d6)  (ppm): 189.6 (s, C4), 144.4 (s, 
C8a), 134.4 (d, C7), 131.7 (d, C5), 119.0 (s, C4a), 116.4 (d, C6), 114.1 (d, C8), 72.1 
(d, C2), 39.6 [s, C(CH3)3], 24.7 [q, C(CH3)3]; EI-MS: m/z (%) = 220 (M
+
, 17), 203 
(15), 171 (19), 163 (100), 129 (23), 91 (24), 77 (20), 41 (47); CI-MS: m/z (%) = 221 
(MH
+
, 100), 189 (33), 187 (24), 163 (21), 131 (25); HRMS: m/z calcd for C12H17N2S 
(MH
+
), 221.1107; found, 221.1110. 
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2-Methyl-1,2-dihydro-3H-quinazoline-4-thione (6) 
Mp: 149-151 C; 1H NMR (DMSO-d6)  (ppm): 10.15 (s, exch., 1H, NH), 8.05 (d, J = 
8 Hz, 1H, H5), 7.27 (app. t, J = 8 Hz, 1H, H7), 6.93 (s, exch., 1H, NH), 6.70-6.67 (m, 
2H, H6 and H8), 4.75 (q, J = 6 Hz, 1H, H2), 1.38 (d, J = 6 Hz, 3H, CH3); 
13
C NMR 
(DMSO-d6)  (ppm): 190.2 (s, C4), 145.2 (s, C8a), 134.1 (d, C7), 131.9 (d, C5), 120.3 
(s, C4a), 117.8 (d, C6), 115.0 (d, C8), 61.4 (d, C2), 20.5 (q, CH3); EI-MS: m/z (%) = 
178 (M
+
, 90), 163 (100), 145 (64), 143 (53), 136 (22), 129 (27), 104 (33), 91 (29), 77 
(36), 42 (54); CI-MS: m/z (%) = 179 (MH
+
, 69), 162 (13), 147 (100), 145 (81); 
HRMS: m/z calcd for C9H11N2S (MH
+
), 179.0637; found, 179.0635. 
 
4.2 4-Substituted 2-alkyl-1,2-dihydroquinazolines (11-18); general procedure 
A solution of alkyllithium (2.2 mmol) was added to a cold (-78 C), stirred solution of 
7, 8 or 9 (2.0 mmol) in anhydrous THF (10 mL) under N2.  The reaction mixture was 
stirred at –78 C for 1 h then removed from the cooling bath and allowed to warm to 
r.t.  The reaction mixture was diluted with Et2O (10 mL) then quenched with aq sat. 
NH4Cl (10 mL).  The organic layer was separated, washed with H2O (2 x 10 mL), 
dried (MgSO4), and evaporated under reduced pressure.  The residue obtained was 
purified by column chromatography (silica gel; Et2O-hexane, 1:4) to give the pure 
product. 
 
2-Butyl-4-(methylthio)-1,2-dihydroquinazoline (11) 
Mp: 32-33 C; 1H NMR (CDCl3)  (ppm): 7.34 (dd, J = 8, 1 Hz, 1H, H5), 7.07 (app. 
dt, J = 1, 8 Hz, 1H, H7), 6.60 (app. dt, J = 1, 8 Hz, 1H, H6), 6.45 (br d, J = 8 Hz, 1H, 
H8), 4.75 (t, J = 6 Hz, 1H, H2), 3.91 (br s, exch., 1H, NH), 2.33 (s, 3H, SCH3), 1.78-
1.61 (m, 2H, CH2), 1.48-1.25 (m, 4H, 2CH2), 0.84 (t, J = 6 Hz, 3H, CH3); 
13
C NMR 
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(CDCl3)  (ppm): 161.3 (s, C4), 143.8 (s, C8a), 132.3 (d, C7), 124.2 (d, C5), 117.0 (s, 
C4a), 116.9 (d, C6), 113.0 (d, C8), 69.4 (d, C2), 35.5 (t, CH2), 26.0 (t, CH2), 21.6 (t, 
CH2), 13.1 (q, CH3), 11.2 (q, SCH3); EI-MS: m/z (%) = 234 (M
+
, 3), 190 (12), 177 
(100), 147 (22), 129 (12), 118 (11), 102 (12), 77 (8), 41 (18); CI-MS: m/z (%) = 235 
(MH
+
, 100), 205 (69), 203 (39), 189 (25), 187 (41); HRMS: m/z calcd for C13H19N2S 
(MH
+
), 235.1263; found, 235.1263. 
 
2-tert-Butyl-4-(methythio)-1,2-dihydroquinazoline (12) 
Mp: 31-32 C; 1H NMR (CDCl3)  (ppm): 7.30 (dd, J = 8, 1 Hz, 1H, H5), 7.08 (app. 
dt, J = 1, 8 Hz, 1H, H7), 6.58 (app. dt, J = 1, 8 Hz 1H, H6), 6.44 (dd, J = 8, 1 Hz, 1H, 
H8), 4.45 (s, 1H, H2), 3.88 (br s, exch., 1H, NH), 2.33 (s, 3H, CH3), 0.97 [s, 9H, 
C(CH3)3]; 
13
C NMR (CDCl3)  (ppm): 160.6 (s, C4), 144.5 (s, C8a), 131.3 (d, C7), 
123.9 (d, C5), 116.6 (d, C6), 116.2 (s, C4a), 112.5 (d, C8), 77.2 (d, C2), 35.2 [s, 
C(CH3)3], 24.3 [q, C(CH3)3], 11.1 (q, SCH3); EI-MS: m/z (%) = 234 (M
+
, 4), 190 (14), 
177 (100), 161 (20), 144 (21), 129 (12), 118 (16), 102 (17), 77 (8), 41 (20); CI-MS: 
m/z (%) = 235 (MH
+
, 100), 189 (25), 187 (41), 177 (18), 147 (11), 131 (18); HRMS: 
m/z calcd for C13H19N2S (MH
+
), 235.1263; found, 235.1262. 
 
2-Methyl-4-(methylthio)-1,2-dihydroquinazoline (13) 
Mp: 70-71 C; 1H NMR (CDCl3)  (ppm): 7.37 (dd, J = 8, 1 Hz, 1H, H5), 7.11 (app. 
dt, J = 1, 8 Hz, 1H, H7), 6.63 (app. dt, J = 1, 8 Hz, 1H, H6), 6.48 (br d, J = 8 Hz, 1H, 
H8), 4.90 (q, J = 6 Hz, 1H, H2), 3.91 (br s, exch., 1H, NH), 2.34 (s, 3H, SCH3), 1.42 
(d, J = 6 Hz, 3H, CH3); 
13
C NMR (CDCl3)  (ppm): 163.2 (s, C4), 145.3 (s, C8a), 
132.9 (d, C7), 125.7 (d, C5), 118.6 (d, C6), 118.4 (s, C4a), 114.5 (d, C8), 67.0 (d, C2), 
23.7 (q, CH3), 12.7 (q, SCH3); EI-MS: m/z (%) = 192 (M
+
, 12), 190 (10), 177 (100), 
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145 (22), 118 (14), 102 (21), 76 (15); CI-MS: m/z (%) = 193 (MH
+
, 100), 177 (17), 
147 (30), 145 (41); HRMS: m/z calcd for C10N13N2S (MH
+
), 193.0794; found, 
193.0794. 
 
2-Butyl-4-(ethylthio)-1,2-dihydroquinazoline (14) 
Mp: 136-38 C; 1H NMR (CDCl3)  (ppm): 7.32 (dd, J = 8, 1 Hz, 1H, H5), 7.05 (app. 
dt, J = 1, 8 Hz, 1H, H7), 6.57 (app. dt, J = 1, 8 Hz, 1H, H6), 6.42 (dd, J = 8, 1 Hz, 1H, 
H8), 4.72 (t, J = 6 Hz, 1H, H2), 3.92 (br s, exch., 1H, NH), 2.95 (q, J = 7 Hz, 2H, 
SCH2), 1.73-1.60 (m, 2H, CH2), 1.45-1.26 (m, 4H, 2CH2), 1.24 (t, J = 7 Hz, 3H, 
SCH2CH3), 0.83 (t, J = 6 Hz, 3H, CH3);
13
C NMR (CDCl3)  (ppm): 162.1 (s, C4), 
145.4 (s, C8a), 132.8 (d, C7), 125.7 (d, C5), 118.5 (s, C4a), 118.3 (d, C6), 114.4 (d, 
C8), 70.8 (d, C2), 37.0 (t, CH2), 27.5 (t, CH2), 23.9 (t, CH2), 23.1 (t, SCH2), 14.7 (q, 
CH3), 14.5 (q, CH3); EI-MS: m/z (%) = 248 (M
+
, 2), 217 (29), 204 (40), 191 (100), 
163 (79), 161 (41), 147 (80), 129 (38), 102 (35), 92 (24), 77 (21), 65 (20), 41 (53); CI-
MS: m/z (%) = 249 (MH
+
, 100), 247 (30), 222 (12), 219 (22), 205 (31), 189 (22); 
HRMS: m/z calcd for C14H21N2S (MH
+
), 249.1420; found, 249.1421. 
 
2-tert-Butyl-4-(ethylthio)-1,2-dihydroquinazoline (15) 
175-177 C; 1H NMR (CDCl3)  (ppm): 7.27 (dd, J = 8, 1 Hz, 1H, H5), 7.02 (app. dt, 
J = 1, 8 Hz, 1H, H7), 6.53 (app. dt, J = 1, 8 Hz 1H, H6), 6.39 (dd, J = 8, 1 Hz, 1H, 
H8), 4.37 (s, 1H, H2), 3.87 (br s, exch., 1H, NH), 3.00-2.85 (m, 2H, CH2), 1.24 (t, J = 
7 Hz, 3H, CH3), 0.94 [s, 9H, C(CH3)3]; 
13
C NMR (CDCl3)  (ppm): 161.6 (s, C4), 
146.1 (s, C8a), 132.7 (d, C7), 125.4 (d, C5), 118.1 (d, C6), 117.8 (s, C4a), 114.1 (d, 
C8), 78.6 (d, C2), 36.5 [s, C(CH3)3], 25.8 [q, C(CH3)3], 23.8 (t, CH2), 15.1 (q, CH3); 
EI-MS: m/z (%) = 248 (M
+
, 2), 217 (9), 191 (95), 163 (64), 147 (73), 129 (40), 118 
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(29), 103 (21), 92 (22), 77 (25), 65 (37), 57 (83), 41 (100); CI-MS: m/z (%) = 249 
(MH
+
, 100), 247 (54), 205 (50), 191 (20), 189 (18); HRMS: m/z calcd for C14H21N2S 
(MH
+
), 249.1420; found, 249.1419. 
 
2-Butyl-4-methoxy-1,2-dihydroquinazoline (16) 
Oil; 
1
H NMR (CDCl3)  (ppm): 7.34 (dd, J = 8, 1 Hz, 1H, H5), 7.04 (app. dt, J = 1, 8 
Hz, 1H, H7), 6.53 (app. dt, J = 1, 8 Hz, 1 H, H6), 6.37 (dd, J = 8, 1 Hz, 1H, H8), 4.83 
(t, J = 6 Hz, 1H, H2), 3.92 (br s, exch., 1H, NH), 3.69 (s, 3H, OCH3), 1.64-1.59 (m, 
2H, CH2), 1.33-1.21 (m, 4H, 2 CH2), 0.81 (t, J = 7 Hz, 3H, CH3); 
13
C NMR (CDCl3)  
(ppm): 159.4 (s, C4), 147.6 (s, C8a), 132.9 (d, C7), 125.5 (d, C5), 118.0 (d, C6), 113.8 
(d, C8), 113.2 (s, C4a), 69.6 (d, C2), 52.9 (q, OCH3), 38.0 (t, CH2), 27.4 (t, CH2), 23.1 
(t, CH2), 14.5 (q, CH3); EI-MS: m/z (%) = 218 (M
+
, 14), 187 (20), 174 (41), 162 (52), 
161 (100), 147 (81), 130 (24), 120 (57), 103 (25), 92 (64), 65 (23), 41 (55); ESI-MS: 
m/z (%) = 219 (MH
+
, 100), 217 (49), 205 (9), 161 (18); HRMS: m/z calcd for 
C13H19N2O (MH
+
), 219.1492; found, 219.1490. 
 
2-tert-Butyl-4-methoxy-1,2-dihydroquinazoline (17) 
Oil; 
1
H NMR (CDCl3)  (ppm): 7.32 (dd, J = 8, 1 Hz, 1H, H5), 7.03 (app. dt, J = 1, 8 
Hz, 1H, H7), 6.52 (app. dt, J = 1, 8 Hz, 1H, H6), 6.38 (br d, J = 8 Hz, 1H, H8), 4.60 
(s, 1H, H2), 3.89 (br s, exch., 1H, NH), 3.71 (s, 3H, OCH3), 0.90 [s, 9H, C(CH3)3]; 
13
C NMR (CDCl3)  (ppm): 158.7 (s, C4), 148.2 (s, C8a), 132.9 (d, C7), 125.2 (d, 
C5), 117.5 (d, C6), 113.2 (d, C8), 112.4 (s, C4a), 77.5 (d, C2), 52.8 (q, OCH3), 37.2 
[s, C(CH3)3], 25.5 [q, C(CH3)3]; EI-MS: m/z (%) = 218 (M
+
, 2), 201 (10), 161 (100), 
120 (18), 92 (16), 40 (23); ESI-MS: m/z (%) = 219 (MH
+
, 100), 217 (29), 161 (39); 
HRMS: m/z calcd for C13H19N2O (MH
+
), 219.1492; found, 219.1491. 
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4-Methoxy-2-methyl-1,2-dihydroquinazoline (18) 
Oil; 
1
H NMR (CDCl3)  (ppm): 7.36 (dd, J = 8, 1 Hz, 1H, H5), 7.06 (app. dt, J = 1, 8 
Hz, 1H, H7), 6.57 (app. dt, J = 1, 8 Hz, 1H, H6), 6.41 (dd, J = 8, 1 Hz, 1H, H8), 4.99 
(q, J = 6 Hz, 1H, H2), 3.99 (br s, exch., 1H, NH), 3.71 (s, 3H, OCH3), 1.35 (d, J = 6 
Hz, 3H, CH3); 
13
C NMR (CDCl3)  (ppm): 159.8 (s, C4), 147.7 (s, C8a), 133.0 (d, 
C7), 125.6 (d, C5), 118.2 (d, C6), 113.9 (d, C8), 113.2 (s, C4a), 65.8 (d, C2), 53.1 (q, 
OCH3), 15.9 (q, CH3); EI-MS: m/z (%) = 176 (M
+
, 64), 174 (33), 162 (60), 161 (100), 
145 (31), 130 (41), 120 (88), 103 (55), 92 (86), 76 (39), 65 (52), 56 (54), 42 (52); CI-
MS: m/z (%) = 177 (MH
+
, 100), 175 (52), 161 (6), 145 (7); HRMS: m/z calcd for 
C10H13N2O (MH
+
), 177.1022; found, 177.1021. 
 
2-tert-Butyl-1,2-dihydro-1H-quinazolin-4-one (19) 
Mp 203-204 C; 1H NMR (DMSO-d6)  (ppm): 7.63 (dd, J = 8, 1 Hz, 1H, H5), 7.13 
(app. dt, J = 1, 8 Hz, 1H, H7), 7.11 (d, J = 2 Hz, exch., 1H, NH), 6.70 (br d, J = 8 Hz, 
1H, H8), 6.57 (app. dt, J = 1, 8 Hz, 1H, H6), 5.75 (br s, exch., 1H, NH), 4.41 (d, J = 2 
Hz, 1H, H2), 0.91 [s, 9H, C(CH3)3]; 
13
C NMR (DMSO-d6)  (ppm): 164.9 (s, C4), 
148.3 (s, C8a), 133.4 (d, C7), 127.5 (d, C5), 116.9 (d, C6), 114.2 (s, C4a), 114.0 (d, 
C8), 73.0 (d, C2), 36.8 [s, C(CH3)3], 24.5 [q, C(CH3)3]; EI-MS: m/z (%) = 204 (M
+
, 
1), 147 (34), 92 (14), 57 (78), 41 (100); CI-MS: m/z (%) = 205 (MH
+
, 100), 203 (48), 
164 (9), 147 (22); HRMS: m/z calcd for C12H17N2O (MH
+
), 205.1335; found, 
205.1335. 
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4.3 4,4-Dialkyl-2-phenyl-3,4-dihydroquinazolines 22-24; general procedure 
A solution of alkyllithium (4.4 mmol) was added to a cold (-78 C), stirred solution of 
20 or 21 (2.0 mmol) in anhydrous THF (10 mL) under N2. The reaction mixture was 
stirred at –78 C for 1 h then removed from the cooling bath and allowed to warm to 
r.t., diluted with Et2O (10 mL), then quenched with aq. sat. NH4Cl (10 mL). The 
organic layer was separated, washed with H2O (2 x 10 mL), dried (MgSO4), and 
evaporated under reduced pressure. The residue obtained was purified by column 
chromatography (silica gel; Et2O-hexane, 1:4) to give the pure product 22, 23 or 24. 
 
4,4-Dibutyl-2-phenyl-3,4-dihydroquinazoline (22) 
Mp: 161 C (lit. 154-155 °C [19]); 1H NMR (CDCl3)  (ppm): 7.87-7.85 (m, 2H, 
ArH), 7.51-7.45 (m, 3H, ArH), 7.29-7.21 (m, 2H, ArH), 7.08-7.06 (m, 2H, ArH), 4.94 
(br s, exch., 1H, NH), 1.95 [app. dt, J = 4, 13 Hz, 2H, (CHaHb)2], 1.63 [m, 2H, 
(CHaHb)2], 1.41 [m, 2H, (CHcHd)2], 1.33-1.18 [m, 6H, (CHcHd)2 + 2CH2], 0.85 (t, J = 
7 Hz, 6H, 2CH3); 
13
C NMR (CDCl3)  (ppm): 154.0 (s, C2), 142.1 (s, C8a), 136.2 (s, 
C1 of Ph), 130.9 (d, C4 of Ph), 129.1 (d, C3 of Ph), 128.1 (d, C5), 126.9 (d, C7), 
126.8 (d, C2 of Ph), 124.9 (d, C6), 124.9 (d, C8), 124.3 (s, C4a), 59.9 (s, C4), 45.4 (t, 
CH2), 26.6 (t, CH2), 23.4 (t, CH2), 14.4 (q, CH3); EI-MS: m/z (%) = 320 (M
+
, 2), 263 
(100), 220 (18), 117 (8); CI-MS: m/z (%) = 321 (MH
+
, 100), 263 (46); HRMS: m/z 
calcd for C22H29N2 (MH
+
), 321.2325; found, 321.2330. 
 
4,4-Dimethyl-2-phenyl-3,4-dihydroquinazoline (23) 
Mp: 100-101 C; 1H NMR (CDCl3)  (ppm): 7.74-7.42 (m, 2H, ArH), 7.38-7.32 (m, 
3H, ArH), 7.17-7.12 (m, 2H, ArH), 7.09-6.98 (m, 2H, ArH), 4.65 (br s, exch., 1H, 
NH), 1.51 (s, 6H, 2CH3); 
13
C NMR (CDCl3)  (ppm): 154.1 (s, C2), 141.9 (s, C8a), 
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136.1 (s, C1 of Ph), 131.0 (d, C4 of Ph), 130.8 (s, C4a), 129.0 (d, C3 of Ph), 128.3 (d, 
C5), 127.1 (d, C2 of Ph), 125.2 (d, C7), 124.4 (d, C6), 123.5 (d, C8), 53.3 (s, C4), 
32.2 (q, CH3); CI-MS: m/z (%) = 237 (MH
+
, 100), 221 (13); HRMS: m/z calcd for 
C16H17N2 (MH
+
), 237.1386; found, 237.1385. 
 
4,4-Di-tert-butyl-2-phenyl-3,4-dihydroquinazoline (24) 
Oil; 
1
H NMR (CDCl3)  (ppm): 7.81-7.79 (m, 2H, ArH), 7.45-7.39 (m, 4H, ArH), 
7.18-6.90 (m, 3H, ArH), 5.60 (br s, exch., 1H, NH), 1.12 [s, 18H, 2C(CH3)3]; 
13
C 
NMR (CDCl3)  (ppm): 154.0 (s, C2), 144.5 (s, C8a), 136.1 (s, C1 of Ph), 131.0 (d, 
C4 of Ph), 129.0 (d, C3 of Ph), 128.6 (d, C5), 126.9 (d, C7), 126.5 (d, C2 of Ph), 
125.9 (d, C6), 125.7 (d, C8), 122.9 (s, C4a), 67.6 (s, C4), 45.3 [s, C(CH3)3], 30.1 [q, 
C(CH3)3]; EI-MS: m/z (%) = 320 (M
+
, 1), 263 (71), 247 (22), 233 (18), 220 (15), 205 
(13), 180 (10), 160 (12), 104 (15), 77 (32), 57 (100), 41 (88); CI-MS: m/z (%) = 321 
(MH
+
, 100), 263 (43); HRMS: m/z calcd for C22H29N2 (MH
+
), 321.2325; found, 
321.2325. 
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